Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia.
作者信息
de Weerdt Iris, van Hoeven Vera, Munneke J Marius, Endstra Sanne, Hofland Tom, Hazenberg Mette D, Kater Arnon P
机构信息
Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands.
Department of Experimental Immunology, Academic Medical Center, Amsterdam, the Netherlands.
出版信息
Haematologica. 2016 Nov;101(11):e461-e464. doi: 10.3324/haematol.2016.144725. Epub 2016 Aug 4.
Abstract
摘要
相似文献
1
Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia.
Haematologica. 2016 Nov;101(11):e461-e464. doi: 10.3324/haematol.2016.144725. Epub 2016 Aug 4.
2
Reconstitution of innate immunity in B-chronic lymphocytic leukemia: time to reconsider the possibilities.
Leukemia. 2003 Oct;17(10):1945-7. doi: 10.1038/sj.leu.2403082.
3
Cell-mediated immunity in chronic lymphocytic leukemia.
Leuk Lymphoma. 2010 Oct;51(10):1775-6. doi: 10.3109/10428194.2010.514083.
4
Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments--peripheral blood, bone marrow and lymph node.
Cancer Biother Radiopharm. 1998 Aug;13(4):269-74. doi: 10.1089/cbr.1998.13.269.
5
Dameshek W. Chronic lymphocytic leukemia-an accumulative disease of immunologically incompetent lymphocytes. Blood. 1967;29(4):566-584.
Blood. 2016 Jul 28;128(4):465. doi: 10.1182/blood-2016-05-716159.
6
The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model.
Hematol Oncol Clin North Am. 2004 Aug;18(4):849-62, viii. doi: 10.1016/j.hoc.2004.04.004.
7
Levels of expression of CD45 for normal lymphocytes in different leukemic cases by flowcytometry.
Indian J Pathol Microbiol. 2020 Jul-Sep;63(3):505-506. doi: 10.4103/IJPM.IJPM_188_19.
8
[The use of biochips for immunomorphological diagnosis of chronic lymphocytic leukemia].
Vopr Onkol. 2013;59(6):761-5.
9
Innate immune signaling in CLL.
Blood. 2016 Jan 28;127(4):376-8. doi: 10.1182/blood-2015-11-679845.
10
CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
Int J Cancer. 2004 Apr 10;109(3):402-11. doi: 10.1002/ijc.11723.
引用本文的文献
1
Cellular Cosmetics: How Innate Lymphoid Cells Can Recontour the Tumour Microenvironment.
Eur J Immunol. 2025 Sep;55(9):e70041. doi: 10.1002/eji.70041.
2
Innate Lymphoid Cells.
Adv Exp Med Biol. 2025;1476:31-46. doi: 10.1007/978-3-031-85340-1_2.
3
Circulating subpopulations of non-cytotoxic ILCs in diffuse large B-cell lymphoma.
Ann Hematol. 2025 Feb;104(2):1105-1115. doi: 10.1007/s00277-024-05831-8. Epub 2024 Jun 11.
4
Twenty-One Flavors of Type 1 Innate Lymphoid Cells with PD-1 (Programmed Cell Death-1 Receptor) Sprinkles.
Discov Immunol. 2023 Feb 7;2(1):kyad003. doi: 10.1093/discim/kyad003. eCollection 2023.
5
Immunometabolic reprogramming, another cancer hallmark.
Front Immunol. 2023 May 19;14:1125874. doi: 10.3389/fimmu.2023.1125874. eCollection 2023.
6
An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies.
Front Oncol. 2023 Apr 6;13:1135812. doi: 10.3389/fonc.2023.1135812. eCollection 2023.
7
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia.
Haematologica. 2023 Sep 1;108(9):2396-2409. doi: 10.3324/haematol.2022.282140.
8
Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
PLoS One. 2023 Feb 13;18(2):e0281688. doi: 10.1371/journal.pone.0281688. eCollection 2023.
9
Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential.
Cancers (Basel). 2022 Nov 24;14(23):5787. doi: 10.3390/cancers14235787.
10
The soldiers needed to be awakened: Tumor-infiltrating immune cells.
Front Genet. 2022 Sep 29;13:988703. doi: 10.3389/fgene.2022.988703. eCollection 2022.
本文引用的文献
1
Perturbation of the normal immune system in patients with CLL.
Blood. 2015 Jul 30;126(5):573-81. doi: 10.1182/blood-2015-03-567388. Epub 2015 Jun 17.
2
CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis.
Haematologica. 2015 Jul;100(7):e257-60. doi: 10.3324/haematol.2014.119602. Epub 2015 Feb 20.
3
Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.
Leukemia. 2015 Aug;29(8):1676-83. doi: 10.1038/leu.2015.50. Epub 2015 Feb 24.
4
The biology of innate lymphoid cells.
Nature. 2015 Jan 15;517(7534):293-301. doi: 10.1038/nature14189.
5
Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism.
J Immunol. 2015 Jan 15;194(2):827-35. doi: 10.4049/jimmunol.1401350. Epub 2014 Dec 10.
6
Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.
PLoS One. 2014 Oct 6;9(10):e108326. doi: 10.1371/journal.pone.0108326. eCollection 2014.
7
Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.
Blood. 2014 Jul 31;124(5):812-21. doi: 10.1182/blood-2013-11-536888. Epub 2014 May 22.
8
Human innate lymphoid cells.
Blood. 2014 Jul 31;124(5):700-9. doi: 10.1182/blood-2013-11-427781. Epub 2014 Apr 28.
9
Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.
Mucosal Immunol. 2014 Jul;7(4):842-56. doi: 10.1038/mi.2013.101. Epub 2013 Nov 27.
10
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model.
J Exp Med. 2013 May 6;210(5):917-31. doi: 10.1084/jem.20122308.
Zotero 插件